Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA

Approved

STANDARD

FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA

Glaxosmithkline S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 13, 2025
Approval ID: 66d361637aa574c2
Company: Glaxosmithkline S.A.
Type: Standard

Approval Details

Approval Id: 66d361637aa574c2
Drug Cima Aemps Name: FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Register Number: 90137
Holder Company Name: Glaxosmithkline S.A.
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-sa
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2025-02-13
Dosage Form: SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 0,5 ml
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline S.A.
Company Detail Path: /organization/glaxosmithkline-sa

Company Information

Pharmaceutical Company Name: GLAXOSMITHKLINE SA
Country Name: Spain
City Name: tres cantos,madrid,country_es
Address: CALLE DE SEVERO OCHOA (- PQ TECNOLOGICO DE MADRID) 2

Active Ingredients

VIRUS INFLUENZA GRIPE A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVADO

15 Microgramo(s) Hemaglutinina

VIRUS INFLUENZA GRIPE A/THAILAND/8/2022 (H3N2) IVR-237 CEPA SIMILAR A (A/THAILAND/8/2022)

15 Microgramo(s) Hemaglutinina

VIRUS INFLUENZA GRIPE CEPA SIMILAR A B/AUSTRIA/1359417/2021-(B/AUSTRIA/1359417/2021, BVR-26)

15 Microgramo(s) Hemaglutinina

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 13, 2025

Approval ID

66d361637aa574c2

Type

Standard

Back to CIMA-AEMPS Approvals